Profiteers at Pfizer Reach Cosmic High of $27 Billion in Record Sales in 2021 Off its Deadly COVID Shots that Have Government Granted Immunity for Any Injury or Death it Causes

From [HERE] Thanks to its COVID shots and its COVID infection antiviral treatment, Paxlovid, Pfizer has marked a record high in its quarterly sales. In all, the company’s revenue increased by 47%, top $27.7 billion in 2021.

It’s expecting even more in 2022, with an anticipated $32 billion incoming from its COVID jab and $22 billion for Paxlovid. Complete immunity fuels the cosmic profits.

The federal government has given complete immunity to Pfizer, Moderna, and J&J for any injury caused by their Covid-19 vaccines.  That’s right: you cannot sue them if you are injured by their Covid-19 vaccine.  (See Note 1 to read the law yourself.)  So, while their product may not give you immunity, Pfizer and Moderna are guaranteed immunity.  Said immunity also shields doctors, hospitals and any other persons who administer or coerce people to take deadly COVID injections.

And it gets even worse.  These companies are even immune for – hold your breath – willful misconduct.  That may sound crazy, but it is shockingly true.  You can only sue them for willful misconduct if the federal government first sues them for such conduct.  (See Note 2 below to read the law yourself.)  And what are the odds the federal government will do so after wildly promoting the vaccine?  About as likely as the FDA ever admitting they promoted a vaccine that caused widespread harm. [MORE] and  [MORE]

Note 1. Pursuant to 42 U.S.C. § 247d-6d the federal government “Declaration pursuant to section 319F-3 of the Public Health Service Act to provide liability immunity for activities related to medical countermeasures against COVID-19” provides that “manufacturers” of “any vaccine, used to treat, … prevent or mitigate COVID-19” shall enjoy “[l]iablity immunity ,” including, “from suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a [COVID-19 vaccine].”

Note 2. Pursuant to 42 U.S.C. § 247d-6d(c)(5) “If an act or omission by a manufacturer or distributor with respect to a covered countermeasure, which act or omission is alleged under subsection (e)(3)(A) to constitute willful misconduct, … such act or omission shall not constitute ‘willful misconduct’ … if—(i)neither the Secretary nor the Attorney General has initiated an enforcement action with respect to such act or omission; or (ii)such an enforcement action has been initiated and the action has been terminated or finally resolved without a covered remedy.”